Kumiko Ogawa Selected Research

Corn Oil (Oil, Corn)

10/2021	A 13-week subchronic toxicity study of 2-(l-menthoxy)ethanol in F344 rats.
5/2013	High susceptibility of heterozygous (+/fa) lean Zucker rats to 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis.
12/2012	Possible involvement of sulfotransferase 1A1 in estragole-induced DNA modification and carcinogenesis in the livers of female mice.
1/2012	Female heterozygous (+/fa) Zucker rats as a novel leptin-related mammary carcinogenesis model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kumiko Ogawa Research Topics

Disease

42	Carcinogenesis 03/2022 - 02/2002
41	Neoplasms (Cancer) 01/2024 - 02/2002
23	Body Weight (Weight, Body) 12/2021 - 10/2002
13	Hyperplasia 12/2023 - 03/2003
10	Prostatic Neoplasms (Prostate Cancer) 02/2015 - 04/2005
9	Carcinoma (Carcinomatosis) 01/2021 - 03/2003
7	Fibrosis (Cirrhosis) 04/2024 - 04/2003
7	Inflammation (Inflammations) 01/2024 - 04/2003
7	Adenocarcinoma 02/2015 - 02/2002
7	Hepatocellular Carcinoma (Hepatoma) 09/2013 - 10/2002
6	Hypertrophy 04/2024 - 10/2006
6	Neoplasm Metastasis (Metastasis) 09/2013 - 10/2002
5	Necrosis 12/2023 - 04/2014
4	Chronic Pancreatitis 04/2005 - 04/2003
3	Chromosome Aberrations (Chromosome Abnormalities) 01/2023 - 09/2013
3	Urinary Bladder Neoplasms (Bladder Cancer) 01/2022 - 01/2020
3	Papilloma (Papillomatosis) 01/2017 - 01/2012
2	Chronic Renal Insufficiency 04/2024 - 10/2023
2	Lung Injury 01/2024 - 09/2022
2	Lung Diseases (Lung Disease) 01/2024 - 10/2022
2	Hemorrhage 12/2023 - 01/2019
2	COVID-19 10/2022 - 09/2022
2	Asthma (Bronchial Asthma) 02/2021 - 01/2012
2	Infections 07/2013 - 09/2005
2	Aberrant Crypt Foci 01/2011 - 06/2005
1	Bites and Stings (Sting) 01/2024
1	Connective Tissue Diseases (Connective Tissue Disease) 01/2024
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2024

Drug/Important Bio-Agent (IBA)

20	CarcinogensIBA 01/2024 - 10/2002
10	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 05/2006
7	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 01/2021 - 10/2002
7	Messenger RNA (mRNA)IBA 10/2020 - 04/2003
7	AndrogensIBA 02/2015 - 04/2005
6	Biomarkers (Surrogate Marker)IBA 04/2024 - 01/2022
6	Drinking WaterIBA 01/2017 - 10/2002
5	AminesIBA 12/2023 - 01/2020
5	4-(methylthio)-3-butenyl isothiocyanateIBA 01/2019 - 03/2013
4	Proteins (Proteins, Gene)FDA Link 01/2024 - 03/2008
4	2-toluidine (o-toluidine)IBA 01/2022 - 01/2019
4	Corn Oil (Oil, Corn)IBA 10/2021 - 01/2012
4	2- amino- 1- methyl- 6- phenylimidazo(4,5- b)pyridineIBA 01/2011 - 02/2002
4	N-nitrosomorpholineIBA 08/2007 - 10/2002
3	Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA 01/2024 - 09/2022
3	ButylhydroxybutylnitrosamineIBA 01/2022 - 03/2008
3	2-anisidine (o-anisidine)IBA 01/2022 - 01/2019
3	Glutathione Transferase (Glutathione S-Transferase)IBA 01/2021 - 03/2013
3	Caspase 3 (Caspase-3)IBA 08/2017 - 11/2009
3	Bromodeoxyuridine (BrdU)IBA 01/2017 - 07/2003
3	phenethyl isothiocyanate (PEITC)IBA 12/2015 - 03/2003
3	nobiletinIBA 01/2011 - 12/2004
3	benzocycloheptapyridineIBA 01/2011 - 02/2002
3	Tumor Viral Antigens (Large T Antigen)IBA 04/2007 - 04/2005
3	probasinIBA 04/2007 - 04/2005
3	Transforming Growth Factor beta1 (TGF beta 1)IBA 04/2005 - 04/2003
3	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 04/2005 - 04/2003
3	Lisinopril (Prinivil)FDA LinkGeneric 04/2005 - 04/2003
2	Hormones (Hormone)IBA 04/2024 - 10/2022
2	Fibronectins (Fibronectin)IBA 04/2024 - 10/2023
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 04/2024 - 01/2012
2	InterferonsIBA 01/2024 - 04/2005
2	Tryptophan (L-Tryptophan)FDA Link 01/2024 - 10/2022
2	Indicators and Reagents (Reagents)IBA 01/2024 - 01/2015
2	KynurenineIBA 01/2024 - 10/2022
2	alizarinIBA 03/2022 - 04/2014
2	Fatty Acids (Saturated Fatty Acids)IBA 02/2021 - 07/2003
2	AcetyltransferasesIBA 01/2021 - 01/2020
2	VimentinIBA 01/2021 - 03/2011
2	acetamideIBA 01/2021 - 10/2020
2	guanylyl-(3'-5')-guanosineIBA 01/2021 - 09/2014
2	DNA AdductsIBA 01/2020 - 05/2003
2	Ether (Diethyl Ether)IBA 03/2019 - 07/2011
2	Diethylhexyl Phthalate (DEHP)IBA 01/2018 - 05/2015
2	alpha-ChlorohydrinIBA 01/2017 - 07/2014
2	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 03/2015 - 04/2003
2	Ellagic AcidIBA 02/2015 - 01/2013
2	LeptinIBA 01/2014 - 01/2012
2	Glutathione PeroxidaseIBA 09/2013 - 12/2007
2	Alkylating AgentsIBA 06/2013 - 05/2006
2	Indomethacin (Indometacin)FDA LinkGeneric 06/2012 - 10/2002
2	Connexin 43 (Connexin43)IBA 05/2012 - 11/2009
2	kuguacin JIBA 03/2012 - 07/2011
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2012 - 01/2004
2	AntigensIBA 01/2012 - 11/2009
2	ConnexinsIBA 02/2010 - 08/2007
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 02/2008 - 04/2005
2	Gap Junction beta-1 ProteinIBA 08/2007 - 01/2005
2	PhytochemicalsIBA 04/2007 - 12/2004
2	auraptenIBA 04/2007 - 12/2004
2	Acetates (Acetic Acid Esters)FDA Link 06/2006 - 12/2004
2	candesartanIBA 04/2005 - 10/2003
2	Angiotensin Receptor AntagonistsIBA 04/2005 - 10/2003
2	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2004 - 10/2002
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2004 - 10/2002
2	Dimenhydrinate (DMH)FDA LinkGeneric 07/2003 - 02/2002
2	1,2-Dimethylhydrazine (1,2 Dimethylhydrazine)IBA 07/2003 - 02/2002
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 01/2024
1	C-Reactive ProteinIBA 01/2024

Therapy/Procedure

5	Oral Administration 01/2023 - 07/2003
5	Therapeutics 12/2017 - 04/2005
4	Chemoprevention 04/2016 - 02/2002